PGT Explained: How Genetic Screening Enhances IVF Success

PGT Explained: How Genetic Screening Enhances IVF Success

In the journey towards successful IVF (In Vitro Fertilization), Preimplantation Genetic Testing (PGT) has emerged as a game-changing technology. This article delves into how PGT enhances IVF success, offering prospective parents an insight into this advanced genetic screening method.

What is Preimplantation Genetic Testing (PGT)?

Preimplantation Genetic Testing refers to the practice of examining the genetic makeup of embryos during an IVF cycle. This process ensures that only genetically healthy embryos are selected for implantation, significantly increasing the chances of a successful pregnancy and a healthy baby.

Types of PGT

  1. PGT-A (Aneuploidy Screening): Tests embryos for the correct number of chromosomes, reducing the risk of chromosomal abnormalities like Down syndrome.
  2. PGT-M (Monogenic/Single Gene Disorders): Screens for specific inherited genetic disorders, such as Cystic Fibrosis or Tay-Sachs disease.
  3. PGT-SR (Structural Rearrangements): Identifies embryos with structural changes in chromosomes, crucial for carriers of chromosomal rearrangements.

The PGT Process in IVF

  • IVF Cycle: Initially, the process begins with the standard IVF procedure, where eggs are fertilized with sperm in a lab.
  • Embryo Development: The fertilized eggs develop into embryos over several days.
  • Embryo Biopsy: A few cells are extracted from each embryo for testing.
  • Genetic Analysis: The biopsied cells undergo genetic analysis to detect any abnormalities.
  • Embryo Selection: Healthy embryos are identified for implantation.

Benefits of PGT in IVF

  • Increased Pregnancy Success Rates: By selecting genetically healthy embryos, PGT can increase the likelihood of a successful pregnancy.
  • Reduction in Miscarriage Risk: Genetic abnormalities are a common cause of miscarriage, which PGT helps to minimize.
  • Prevention of Genetic Disorders: PGT enables couples to avoid passing on certain genetic disorders.
  • Informed Decision-Making: Couples gain insights into their embryos’ genetic health, aiding in informed decision-making.

Identifying Genetic Disorders in Embryos with Preimplantation Genetic Testing (PGT):

PGT-A (Aneuploidy Screening):

This form of testing primarily checks for chromosomal abnormalities rather than specific genetic disorders. It can detect conditions caused by having an abnormal number of chromosomes, such as:

  • Down Syndrome (Trisomy 21)
  • Edwards Syndrome (Trisomy 18)
  • Patau Syndrome (Trisomy 13)
  • Turner Syndrome (Monosomy X)
  • Klinefelter Syndrome (XXY)

PGT-M (Monogenic/Single Gene Disorders):

PGT-M is used to identify specific genetic disorders that are known to be a risk for the couple due to their family history or genetic makeup. Some of the genetic disorders that can be detected include:

  • Cystic Fibrosis
  • Tay-Sachs Disease
  • Sickle Cell Anemia
  • Huntington’s Disease
  • Duchenne Muscular Dystrophy
  • Thalassemia
  • Spinal Muscular Atrophy
  • Fragile X Syndrome
  • Hemophilia
  • BRCA1/BRCA2 (associated with an increased risk of breast and ovarian cancers)

PGT-SR (Structural Rearrangements):

This form of testing is used for individuals or couples known to have chromosomal rearrangements, which can lead to disorders in their offspring. PGT-SR can detect conditions like:

  • Translocations (balanced and unbalanced)
  • Inversions
  • Other structural rearrangements that may lead to genetic disorders or miscarriage


PGT is a powerful tool in modern reproductive medicine, offering hope and reassurance to couples at risk of passing on genetic disorders. By understanding the capabilities and limitations of PGT, couples can make better-informed decisions about their fertility treatments.

Understanding the nuances of PGT and consulting with fertility specialists and genetic counselors can guide couples through the complex yet hopeful journey of building a family free from specific genetic disorders.

FAQs about Preimplantation Genetic Testing

Q1: Is PGT safe for the embryos? A1: Yes, PGT is generally safe. The biopsy is performed by experienced embryologists, and the process is designed to minimize any risk to the embryo’s development.

Q2: Can PGT guarantee a successful pregnancy? A2: While PGT increases the chances of a successful pregnancy by selecting genetically healthy embryos, it cannot guarantee success. Factors like maternal age and overall reproductive health also play significant roles.

Q3: Does PGT test for all genetic diseases? A3: PGT-M can test for specific genetic diseases known to be of concern to the couple, but it does not screen for every possible genetic disorder. The scope of testing depends on the individual case and family history.

Q4: How does PGT differ from amniocentesis? A4: PGT is performed on embryos before pregnancy establishment, whereas amniocentesis is a prenatal test conducted during pregnancy to diagnose chromosomal abnormalities and genetic disorders.

Q5: Is PGT ethical? A5: PGT raises various ethical questions, particularly around the topics of embryo selection and genetic manipulation. Couples need to discuss these concerns with their healthcare provider and consider personal values and beliefs in their decision-making process.

For further information do not hesitate to contact us.